10 research outputs found
1040-C A novel subset of granulocytic MDSCs expressing PD-1 as immunosuppressive regulators and therapeutic targets in gastric cancer
Development of an In-House EphA2 ELISA for Human Serum and Measurement of Circulating Levels of EphA2 in Hypertensive Patients with Renal Dysfunction
Identifying novel biomarkers of kidney function in patients with chronic kidney disease (CKD) has strong clinical value as current measures have limitations. This study aims to develop and validate a sensitive and specific ephrin type-A receptor 2 (EphA2) enzyme-linked immunosorbent assay (ELISA) for human serum, and determine whether its results correlate with traditional renal measures in patients with hypertension. The novel ELISA of the current study was validated and used to measure circulating EphA2 levels in 80 hypertensive patients with and without kidney function decline (eGFR less than 60 mL/min/1.73 m2). Validation of the EphA2 ELISA showed good recovery (87%) and linearity (103%) and no cross-reactivity with other Eph receptors. Patients with kidney function decline had lower diastolic blood pressure, and higher UPCR and EphA2 than those without kidney function decline. The association of age and eGFR with EphA2 was maintained in the stepwise multiple regression analysis. In a multivariate logistic model, EphA2 was associated with a lower eGFR (<60 mL/min/1.73 m2) after adjustment for age, sex, and UPCR. High circulating EphA2 levels have potential application as a clinical biomarker for the presence of CKD in patients with hypertension
Estimating Spatiotemporal Information from Behavioral Sensing Data of Wheelchair Users by Machine Learning Technologies
Recent expansion of intelligent gadgets, such as smartphones and smart watches, familiarizes humans with sensing their activities. We have been developing a road accessibility evaluation system inspired by human sensing technologies. This paper introduces our methodology to estimate road accessibility from the three-axis acceleration data obtained by a smart phone attached on a wheelchair seat, such as environmental factors, e.g., curbs and gaps, which directly influence wheelchair bodies, and human factors, e.g., wheelchair users’ feelings of tiredness and strain. Our goal is to realize a system that provides the road accessibility visualization services to users by online/offline pattern matching using impersonal models, while gradually learning to improve service accuracy using new data provided by users. As the first step, this paper evaluates features acquired by the DCNN (deep convolutional neural network), which learns the state of the road surface from the data in supervised machine learning techniques. The evaluated results show that the features can capture the difference of the road surface condition in more detail than the label attached by us and are effective as the means for quantitatively expressing the road surface condition. This paper developed and evaluated a prototype system that estimated types of ground surfaces focusing on knowledge extraction and visualization
Novel Ridaifen-B Structure Analog Induces Apoptosis and Autophagy Depending on Pyrrolidine Side Chain
Immunotactoid Glomerulopathy with Nontuberculous Mycobacterial Infection: A Novel Association
A 70-year-old woman underwent a renal biopsy due to nephrotic syndrome. She had suffered from nontuberculous mycobacterial infection (NTM) for 14 years. The patient was diagnosed as having membranoproliferative glomerulonephritis (MPGN) type 3 and immunoglobulin (Ig)-associated MPGN based upon LM/erythromycin and IF findings, respectively. In high-magnification imaging, electron-dense deposits showed immunotactoid glomerulopathy (ITG). There was no evidence of hematological cancer, and the patient improved after receiving treatments for NTM. To the best of our knowledge, this patient is the first to show an association between ITG and NTM. Although ITG is generally considered as related to lymphoproliferative disease, it is suggested that ITG is driven by bacterial infection and is a potential outcome of Ig-associated MPGN
The antiapoptotic protein Bcl-xL negatively regulates the bone-resorbing activity of osteoclasts in mice
The B cell lymphoma 2 (Bcl-2) family member Bcl-xL has a well-characterized
antiapoptotic function in lymphoid cells. However, its functions in other cells
— including osteoclasts, which are of hematopoietic origin —
and other cellular processes remain unknown. Here we report an unexpected function of
Bcl-xL in attenuating the bone-resorbing activity of osteoclasts in mice. To
investigate the role of Bcl-xL in osteoclasts, we generated mice with
osteoclast-specific conditional deletion of Bcl-x (referred to
herein as Bcl-x cKO mice) by mating
Bcl-xfl/fl mice with mice in which the gene encoding the
Cre recombinase has been knocked into the cathepsin K locus and
specifically expressed in mature osteoclasts. Although the Bcl-x cKO
mice grew normally with no apparent morphological abnormalities, they developed
substantial osteopenia at 1 year of age, which was caused by increased bone
resorption. Bcl-x deficiency increased the bone-resorbing activity
of osteoclasts despite their high susceptibility to apoptosis, whereas Bcl-xL
overexpression produced the opposite effect. In addition, Bcl-x cKO
osteoclasts displayed increased c-Src activity, which was linked to increased levels
of vitronectin and fibronectin expression. These results suggest that Bcl-xL
attenuates osteoclastic bone-resorbing activity through the decreased production of
ECM proteins, such as vitronectin and fibronectin, and thus provide evidence for what
we believe to be a novel cellular function of Bcl-xL
Anti-apoptotic Molecule Bcl-2 Regulates the Differentiation, Activation, and Survival of Both Osteoblasts and Osteoclasts*
The anti-apoptotic molecule Bcl-2 inhibits apoptosis by preventing cytochrome c release from mitochondria. Although several studies have indicated the importance of Bcl-2 in maintaining skeletal integrity, the detailed cellular and molecular mechanisms remain elusive. Bcl-2−/− mice are growth-retarded and exhibit increased bone volume of the primary spongiosa, mainly due to the decreased number and dysfunction of osteoclasts. Osteoblast function is also impaired in Bcl-2−/− mice. Ex vivo studies on osteoblasts and osteoclasts showed that Bcl-2 promoted the differentiation, activation, and survival of both cell types. Because Bcl-2−/− mice die before 6 weeks of age due to renal failure and cannot be compared with adult wild type mice, we generated Bcl-2−/−Bim+/− mice, in which a single Bim allele was inactivated, and compared them with their Bcl-2+/−Bim+/− littermates. Loss of a single Bim allele restored normal osteoclast function in Bcl-2−/− mice but did not restore the impaired function of osteoblasts, and the mice exhibited osteopenia. These data demonstrate that Bcl-2 promotes the differentiation, activity, and survival of both osteoblasts and osteoclasts. The balance between Bcl-2 and Bim regulates osteoclast apoptosis and function, whereas other pro-apoptotic members are important for osteoblasts